One Center • One Focus • One Team

Dr. Nimmi Kapoor

HomeDr. Nimmi Kapoor

About Dr. Nimmi Kapoor

Dr. Nimmi Kapoor is a surgical oncologist specializing in breast and thyroid conditions. She practices at Breastlink Encino.

Developments in Radiation Therapy and Surgery

A lot of exciting advancements in breast cancer research were announced this past December at the 2014 San Antonio Breast Cancer Symposium (SABCS). In a previous post, we touched upon some of the developments in breast cancer screening, prevention and genetic testing. In this post, we will look at several other interesting updates presented at the 2014 SABCS.

  • Predicting outcome for women with DCIS who avoid radiation.
  • Developments in radiation therapy suggesting women could benefit from shorter courses of radiation therapy as opposed to longer courses.
  • Trends and controversies surround contralateral prophylactic mastectomy.

San Antonio Breast Cancer Symposium 2014

Genomic Testing, […]

SABCS 2014: Breast Cancer Prevention, Screening & Genetic Testing

This year at the San Antonio Breast Cancer Symposium (SABCS) there were two aspects of breast cancer that were clearly emphasized: use of ovarian suppression in premenopausal women with breast cancer and advances in genetic testing for hereditary cancer predisposition.

San Antonio Breast Cancer Symposium 2014
Results of the SOFT trial (further detailed by Dr. Wade Smith in this post), show a clear benefit to the addition of ovarian suppression in women under the age of 35. This benefit resembles that seen with the addition of Herceptin for HER2+ cancer, and now calls for a change in practice management.

The second “call for action” released […]

SABCS 2014: Breast Cancer Radiation Therapy Preview

Every year, some of the world’s leading experts on breast cancer gather for the San Antonio Breast Cancer Symposium (SABCS). One of the premier forums on the subject, SABCS offers physicians and allied health professionals an environment conducive to the exchange of ideas and discussion around current trends in breast cancer research.

This is an excellent opportunity to meet with others passionate about breast health care, as well as to learn about new ways we can help patients. At this year’s SABCS, I am excited to learn more about the results of a trial investigating the use of radiation therapy, new markers for identifying cancer in the blood, advances in genetic […]

Understanding Advancements in Genetic Testing for Breast Cancer

Our understanding of breast cancer is rapidly advancing. Breast cancer is not a single disease entity, but a heterogeneous disease spectrum with numerous genetic alterations involved in its pathogenesis.

  • Some breast cancers are indolent and not life-threatening, while others are very aggressive.
  • Similarly, we find different genetic alterations in different breast cancers.
  • Some of these genetic changes are familial, or the result of genetic mutations passed from parent to child.

The BRCA genes were the first to shed light on familial breast cancer genetics. Now we are capable of screening over a dozen different genes for mutations implicated in breast cancer risk. Navigating these new complexities in genetic testing can be […]

Breast Cancer Genomics

The availability of molecular information on breast cancer genomics is rapidly expanding. Patients who are newly diagnosed with breast cancer can easily be overwhelmed by volumes of information in a very short period of time. The good news is that all of the information available is meant to guide personal decisions for cancer management so that we use biology and science for real-life choices. Knowledge is power.

Next Generation of Breast Cancer | Dr Kapoor

The Next Generation of Breast Cancer

Join Dr. Kapoor on Thursday, October 9 from 6-7:30 pm in Santa Ana for her talk on advances in screening, surveillance and […]

The Importance of Informing Women About Dense Breast Tissue

Across the country, more and more women will be informed when mammography reveals dense breast tissue – and that’s a good thing.

Extremely Dense Breast Tissue | OCMA Talk Orange CountyRhode Island recently joined California and 16 other states with the passage of a breast density inform law requiring radiologists to inform women when screening mammography reveals dense breast tissue. It has been a little more than one year since California’s own breast density inform law went into effect and it is worth taking a moment to remember why it is important to make women aware if they have dense breast tissue.

A Brief […]

2013 SABCS: Bisphosphonate Therapy | Anastrozole

The 2013 San Antonio Breast Cancer Symposium (SABCS) presented many studies that will change how medical professionals screen, diagnose and treat for breast cancer. The following are a few observations from the SABCS 2013 I think women and fellow medical professionals might be interested in.

Adjuvant Bisphosphonate Therapy in Breast Cancer

The meta-analysis of bisphosphonate treatment presented on Thursday will be practice changing. The Overview Analysis evaluated the benefit of bisphosphonates (such as Zometa) in all randomized trials including more than 17,000 women with breast cancer with 15-year follow-up.

Bisphosphonates given at the start of treatment to post-menopausal women with breast cancer can decrease bone recurrence by 34 percent and can significantly decrease […]

By |December 16, 2013|Categories: Cancer Research, Oncology|Tags: |0 Comments

2013 SABCS Wed. Screening & Surgical Insights

The first day of the 2013 San Antonio Breast Cancer Symposium (SABCS) featured the findings of a few breast cancer screening studies in the morning. The afternoon sessions discussed interesting results from surgical trials and updates on managing the axilla. Here are a few observations from the deliberations of Wednesday, December 11.

2013 San Antonio Breast Cancer Symposium Wednesday Morning Observations

Although the benefit of mammography on decreasing late stage cancer presentation are under question the overall decrease in breast cancer mortality is undeniable and commendable.

One study evaluated the benefit of screening MRI on average risk patients showing an increase in cancer detection in 11 women per 1000 screened. All cancers were […]

A Year in Reflection—Excited about the 2013 SABCS

A year in reflection—excited about the 2013 San Antonio Breast Cancer Symposium.

I love my job. As a breast cancer surgeon with Breastlink, I have many roles. I get to take care of patients, who, even if they don’t realize it, take care of me, too. They inspire me probably more than I can ever help them.

“It’s only cancer,” said one of my heroes, “at least I can go to a doctor and get it taken care of.” Or, “Chemo is okay. At least I can still work, a little,” said another one of my heroes. My patients often thank me, but really it is I who am quietly thanking them […]

By |December 11, 2013|Categories: Cancer Research|Tags: |0 Comments

Prophylactic Mastectomy

Prophylactic mastectomies, or “double mastectomy” is a surgical procedure chosen by women to substantially reduce their risk of developing breast cancer. The procedure, also known as a preventive mastectomy or risk-reducing mastectomy, removes nearly all breast tissue, reducing the risk of future breast cancer to less than 1%, even in the highest risk patients.

Breast Cancer Risk Factors

Every woman has a unique set of risk factors to develop breast cancer. According to the American Cancer Society about 1 in 8 women in America will develop invasive breast cancer during their lifetime. However, depending on a range of factors, some women face substantially higher odds.

If you or a loved one has been […]

Load More Posts